Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

Anne Marie Jelsig*, John Gásdal Karstensen, Niels Jespersen, Zohreh Ketabi, Charlotte Lautrup, Karina Rønlund, Lone Sunde, Karin Wadt, Ole Thorlacius-Ussing, Niels Qvist

*Corresponding author for this work

Research output: Contribution to journalReviewResearchpeer-review

10 Citations (Scopus)
19 Downloads (Pure)

Abstract

Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

Original languageEnglish
Article number41
JournalHereditary Cancer in Clinical Practice
Volume19
Number of pages9
ISSN1731-2302
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Keywords

  • Cancer
  • Genetics
  • Guideline
  • Hereditary
  • Management
  • Polyposis
  • Surveillance

Cite this